ELPENHALER^®, has a very strong patent portfolio which aims to secure the protection of the entire ELPENHALER^®product range. The device has more than ninety (90) granted patents and patent applications in several countries, including Europe, USA, Canada, Japan, Australia, Russia, China etc.

The company's IP portfolio also includes trademark protection for ELPENHALER^® and its products  (Formopen^®, Fluticapen^® and Rolenium^®), which are registered in many countries worldwide.

It is noteworthy to mention that the device has received a CE mark approval (class 1).